From WSJopinion: In this week’s Future View, read dispatches from students across the U.S. about whether Covid health protocols are still followed.
Editor’s note: This Future View is about whether health protocols for limiting the spread of Covid-19 are still followed across the U.S.
Next week we’ll ask, “How have the events of the past few months changed your plans for the future?” Students should click here to submit opinions of fewer than 250 words before July 7. The best responses will be published that night.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Coronavirus Today: When customers won't wear masksOur special-edition newsletter breaks down the latest coronavirus news, including the tensions between employees of businesses and patrons who don't want to mask up.
Lire la suite »
Coronavirus Today: 'Our professionalism is being exploited'Our special-edition newsletter breaks down the latest coronavirus news, including the growing anger among California health professionals as cases and deaths surge.
Lire la suite »
Americans not welcome: E.U. bars U.S. travelers over coronavirusThe move is a sign of how the U.S. is seen by Europe and elsewhere as a global coronavirus hotbed.
Lire la suite »
FDA issues rules for coronavirus vaccine developersThe Food and Drug Administration (FDA) issued new rules on Tuesday for the companies developing COVID-19 vaccines. "While the FDA is committed to help expedite this work, we will not cut corners in our decision making, and we're making clear in our guidance what are the data that we need, that should be submitted, to meet our regulatory standards of approval," FDA commissioner Dr. Stephen Hahn said Tuesday during a Senate committee hearing. The guidance states that the primary efficacy endpoint in a placebo-controlled efficacy clinical trial should be at least 50%, meaning the vaccine needs "to reduce the risk of disease caused by COVID-19 by 50%" when compared to the placebo, according to Brad Loncar, a longtime biotech investor and CEO of Loncar Investments. There are a number of drugmakers developing COVID-19 vaccine candidates including AstraZeneca and the University of Oxford, Inovio Pharmaceuticals Inc. , and Moderna Inc. , two of which (Inovio and Moderna) have disclosed preliminary data from their Phase 1 trials. A return to economic normalcy has largely been tied to the arrival of vaccines that can prevent infections from the coronavirus. "There is no guarantee...that we will have a safe and effective vaccine, but we are cautiously optimistic," Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, testified during the same hearing.
Lire la suite »
No Spitting: MLB Unveils Some New Rules Due To The CoronavirusThe rules include a ban on spitting and a threat of immediate ejection if a player or coach gets too close to an umpire or opponent in the course of an argument.
Lire la suite »
Treasury yields retreat as Fed's Powell stresses uncertainty and coronavirus cases surgeU.S. government debt prices were higher Tuesday morning after Federal Reserve Chairman Jerome Powell emphasized the prolonged uncertainty facing the U.S. economy, as coronavirus cases soar in numerous states.
Lire la suite »